vida: research 2026 04 29 #5573

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-29 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-29 06:14:51 +00:00
vida: research session 2026-04-29 — 10 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
4b377f44bb
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 8 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
769692fc76
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-29 06:15 UTC

<!-- TIER0-VALIDATION:769692fc76e760e7587cc3df2c8c8f20e4eb53e3 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-29 06:15 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry appear factually correct, drawing on specific data points and reports cited in the inbox files, such as the MSSP savings figures and GLP-1 coverage decline.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content in the research journal synthesizes information from the various inbox files without direct copy-pasting of evidence paragraphs.
  3. Confidence calibration — The confidence calibration for Belief 3 is appropriately strengthened based on the quantitative evidence presented from MSSP data, and the precision added to the scope of market competition mechanisms is well-justified.
  4. Wiki links — There are no wiki links present in the research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims in the research journal entry appear factually correct, drawing on specific data points and reports cited in the inbox files, such as the MSSP savings figures and GLP-1 coverage decline. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content in the research journal synthesizes information from the various inbox files without direct copy-pasting of evidence paragraphs. 3. **Confidence calibration** — The confidence calibration for Belief 3 is appropriately strengthened based on the quantitative evidence presented from MSSP data, and the precision added to the scope of market competition mechanisms is well-justified. 4. **Wiki links** — There are no wiki links present in the `research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
Member

PR Review: Session 2026-04-29 Research Journal Entry

1. Schema

All files in inbox/queue/ are sources (not claims or entities), so they follow source schema rules and are not evaluated for claim-specific frontmatter requirements; the research journal and musings files are agent working documents without frontmatter requirements.

2. Duplicate/redundancy

The journal entry synthesizes evidence from 11 distinct sources covering different aspects (MSSP savings, GLP-1 coverage trends, DTE channels, MHPAEA enforcement, VBC risk models) with no apparent duplication across the evidence base.

3. Confidence

This is a research journal entry (not a claim file), so confidence calibration does not apply; the entry documents belief testing methodology and evidence synthesis rather than making standalone claims.

No wiki links appear in this diff, so there are no broken links to evaluate.

5. Source quality

The sources cited include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, industry expert commentary (9amHealth on Lilly DTE), MHPAEA statutory reports, and HC Plan data on VBC trends — all credible for healthcare policy/market analysis.

6. Specificity

This is a research journal entry documenting an investigative process rather than a standalone claim file, so specificity requirements for falsifiable claims do not apply; however, the entry does contain specific quantitative findings (MSSP $2.48B savings, full capitation 7%→14%, GLP-1 covered lives 3.6M→2.8M) that are falsifiable.


Overall assessment: This PR adds a research journal session documenting a systematic disconfirmation attempt of Belief 3 using market competition as the counter-argument. The entry follows the established journal format, cites specific quantitative evidence from credible sources, and documents both the disconfirmation methodology and results. The synthesis identifies new patterns (GLP-1 coverage withdrawal, MHPAEA differential reimbursement mechanism) and proposes claim enrichments based on new evidence. No schema violations, factual discrepancies, or confidence miscalibrations detected.

# PR Review: Session 2026-04-29 Research Journal Entry ## 1. Schema All files in `inbox/queue/` are sources (not claims or entities), so they follow source schema rules and are not evaluated for claim-specific frontmatter requirements; the research journal and musings files are agent working documents without frontmatter requirements. ## 2. Duplicate/redundancy The journal entry synthesizes evidence from 11 distinct sources covering different aspects (MSSP savings, GLP-1 coverage trends, DTE channels, MHPAEA enforcement, VBC risk models) with no apparent duplication across the evidence base. ## 3. Confidence This is a research journal entry (not a claim file), so confidence calibration does not apply; the entry documents belief testing methodology and evidence synthesis rather than making standalone claims. ## 4. Wiki links No wiki links appear in this diff, so there are no broken links to evaluate. ## 5. Source quality The sources cited include CMS official reports (MSSP PY2024), Health Affairs peer-reviewed analysis, industry expert commentary (9amHealth on Lilly DTE), MHPAEA statutory reports, and HC Plan data on VBC trends — all credible for healthcare policy/market analysis. ## 6. Specificity This is a research journal entry documenting an investigative process rather than a standalone claim file, so specificity requirements for falsifiable claims do not apply; however, the entry does contain specific quantitative findings (MSSP $2.48B savings, full capitation 7%→14%, GLP-1 covered lives 3.6M→2.8M) that are falsifiable. --- **Overall assessment:** This PR adds a research journal session documenting a systematic disconfirmation attempt of Belief 3 using market competition as the counter-argument. The entry follows the established journal format, cites specific quantitative evidence from credible sources, and documents both the disconfirmation methodology and results. The synthesis identifies new patterns (GLP-1 coverage withdrawal, MHPAEA differential reimbursement mechanism) and proposes claim enrichments based on new evidence. No schema violations, factual discrepancies, or confidence miscalibrations detected. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-29 06:17:24 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-29 06:17:24 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-29 06:20:20 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.